Clinical Trial: A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07513441) titled 'A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)' on March 31.

Brief Summary: The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants with Parkinson's disease.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Parkinson Disease

Intervention: DRUG: Lu AF28996

Capsule administered orally per schedule specified in the arm description.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: H. Lundbeck A/S

Published by HT Digital Content Services with permission from Health Daily Digest....